Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Patients with metastatic castration-resistant prostate cancer have few treatment options after novel hormonal therapy (eg, abiraterone or enzalutamide)
Agarwal et al. 2022 Lancet Oncology 23(7): 899-909
The gold standard of medical therapy for advanced prostate cancer is based on the use of androgen-receptor inhibitors and taxane-based chemotherapy.
Nigro et al. 2022 Expert Review of Anticancer Therapy 22: 191-202
In metastatic castration-resistant prostate cancer, the evidence suggests prioritizing abiraterone befor…